Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva (Adnkronos) - In pazienti con tumore al seno in fase iniziale, positivo per i recettori ormonali e negativo per il recettore 2 del fattore di crescita epidermico umano (Hr+/Her2-), ad alto rischio di recidiva - che include tutti i pazie...

TI POTREBBE INTERESSARE: Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva ... LEGGI TUTTO #CancroSeno #Ribociclib #Tumore #Oncologia #Salute

Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva (Adnkronos) - In pazienti con tumore al seno in fase iniziale, positivo per i recettori ormonali e negativo per il recettore 2 del fattore di crescita epidermico umano (Hr+/Her2-), ad alto rischio di recidiva - che include tutti i pazie...

È ACCADUTO IERI: Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva ... LEGGI TUTTO #CancroSeno #Ribociclib #TumoreAlSeno #Salute #RicercaMedica

Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva (Adnkronos) - In pazienti con tumore al seno in fase iniziale, positivo per i recettori ormonali e negativo per il recettore 2 del fattore di crescita epidermico umano (Hr+/Her2-), ad alto rischio di recidiva - che include tutti i pazie...

Cancro seno in fase iniziale, ok Aifa a ribociclib per ridurre rischio recidiva ... LEGGI TUTTO #CancroSeno #TumoreALeSeno #Ribociclib #Prevenzione #Salute

Kisqali (ribociclib) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento Infarmed

Kisqali (ribociclib) | Relatório de avaliação de financiamento público disponível na Infomed | Deferimento
swki.me/DKvf66yE

#infarmed #medicamentos #financiamentopublico #kisqali #ribociclib

Comparative efficacy of first- versus second-line CDK4/6 inhibition in hormone receptor-positive, HER2-negative metastatic breast cancer - Breast Cancer Research Purpose The greater progression-free survival (PFS) improvements observed in first-line (1L) versus second-line (2L) CDK4/6 inhibitor (CDK4/6i) trials underpin current guideline recommendations establ...

It's clear that CDK inhibitors belong in the first line of treatment for HR+/HER2- breast cancer.

#ribociclib #kisqali #oncology

breast-cancer-research.biomedcentral.com/articles/10....

Thousands more breast cancer patients to benefit from new NHS treatment

#NICE #oncology #breastcancer #breastcancerpatients #NHStreatment #NICEapproved #ribociclib #Kisqali #Novartis #earlystagebreastcancer #NICEfinaldraftguidance #aromataseinhibitor #hormonereceptorpositiveHER2negativeearlybreastcancer #Milestoneforbreastcancercare
www.nice.org.uk/news/article...

Drug that cuts risk of breast cancer returning is approved for use in England Up to 4,000 patients a year with early stage of disease could receive ribociclib, but charities want wider access to drug

Big news in breast cancer care: Ribociclib approved for use in England!
Up to 4,000 early-stage patients could benefit — but charities are pushing for even wider access. #TCSC #BreastCancer #CancerTreatment #HealthNews #Ribociclib

www.theguardian.com/society/2025...

Hey Bluesky, I’m ER/PR+ HERS2- , stage 2B SMX - always looking for knowledge and research from #science #scientists. Wading through benefits of trad meds vs holistic, and who is zooming who. Would love to find peeps here with real knowledge, not snake oil. #breastcancer #ribociclib #cancerresearch

Novartis gene therapy set to enhance SMA treatment - PharmaTimes OAV101 IT expands potential for type II SMA patients

#oncology #Novartis #MHRA #MHRAauthorisation #ribociclib #Breastcancer #Breastcancertherapy #aromataseinhibitor #advancedbreastcancer #MHRAdecision #phaseIIIclinicaltrial #NATALEEclinicaltrial l #overallsurvival #patientoutcomes #NICE #SMC #NHSreimbursement
pharmatimes.com/news/novarti...

Meaning of #ribociclib RIBOCICLIB Drug Used for Hormone-Related Female Breast Cancer . .. ribociclib

1. Recent #FDA approvals:

a). #NATALEE: Adj #Ribociclib in HR+ Stg IIA - III, 400mg 3wks on, 1wk off for 3yrs. 3yr iDFS 90.7% vs 87.6, 3.1% absolute iDFS

b). #INAVO120: Inavolisib + Fulvestrant + Palbo vs Palbo/Fulvestrant HR+ mBC. PFS 15.0 vs 7.3mos (HR 0.43)

2/5

#SABCS24 Day 1 Highlights #CommunityOnc:

1. @FDAOncology Reviews recent approvals: #Ribociclib & #Inavolisib

2. #PADMA: HR+ ET + CDK4/6i vs Chemo 1L

3. #DB06: HR+ TDXd

4. #KN522: biomarker analysis

#OncSky #CanSky @sabcs.bsky.social @drsarahsammons.bsky.social @dr-rshatsky.bsky.social

1/5

Significado de #ribociclib RIBOCICLIB medicamento utilizado para el cáncer de mama femenino relacionado con hormonas... ribociclib

Significado de #ribociclib Medicamento RIBOCICLIB usado para câncer de mama feminino relacionado a hormônios . .. ribociclib

Dr. Abirami Natarajan and Dr. Sara Tolaney (@stolaney1.bsky.social) discuss adjuvant #ribociclib in this
Annals of Oncology editorial.
👀 check it out here:
sciencedirect.com/science/arti...